ASTRAZENECA PLC SPON. ADR - US0463531089 (Stock)
Nasdaq
Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
---|---|---|---|---|---|---|
67,87 USD
![]() |
-0,2059% | 15.04.2025 22:00 | 100,00 | 67,39 | 69,00 | 300,00 |
Contact | |
---|---|
|
AstraZeneca PLC Cambridge Biomedical Campus, 1 Francis Crick Avenue CB2 0AA, Cambridge, GB |
Phone | +44-20-3749-5000 |
Fax | + |
Internet | http://www.astrazeneca.co.uk |
IR Contact/PR Contact | -/- |
Symbol | AZNA |
End of financial year | 31.12.2025 |
Issued capital | 185.179.736.538,00 EUR |
Shareholders | |
---|---|
Freefloat | 76,65% |
Wellington Management Co. LLP | 4,20% |
The Vanguard Group, Inc. | 3,71% |
Investor AB (Investment Company) | 3,33% |
BlackRock Investment Management (UK) Ltd. | 3,18% |
Norges Bank Investment Management | 2,07% |
BlackRock Fund Advisors | 1,99% |
Capital Research & Management Co. (World Investors) | 1,74% |
SSgA Funds Management, Inc. | 1,09% |
Capital Research & Management Co. (Global Investors) | 1,04% |
Goldman Sachs Asset Management LP | 1,01% |
Board | |
---|---|
Dr. Pascal Soriot | Chairman of Managing Board |
Sharon Barr | Member of Executive Committee |
Pam Cheng | Member of Executive Committee |
Marc Dunoyer | Member of Executive Committee |
Leon Wang | Member of Executive Committee |
Iskra Reic | Member of Executive Committee |
David Fredrickson | Member of Executive Committee |
Dr. Ruud Dobber | Member of Executive Committee |
Dr. Aradhana Sarin | Member of Executive Committee |
Susan Galbraith | Member of Executive Committee |
Jeff Pott | Member of Executive Committee |
Michel Demaré | Chairman of Supervisory Board |
Rene Anthony Haas | Member of Supervisory Board |
Philip Broadley | Member of Supervisory Board |
Marcus Wallenberg | Member of Supervisory Board |
Diana Layfield | Member of Supervisory Board |
Birgit Conix | Member of Supervisory Board |
Sherilyn McCoy | Member of Supervisory Board |
Dr. Shu Kam Mok | Member of Supervisory Board |
Dr. Nazneen Rahman | Member of Supervisory Board |
Dr. Euan Ashley | Member of Supervisory Board |
Dr. Aradhana Sarin | Member of Supervisory Board |
Anna Olive Magdelene Manz | Member of Supervisory Board |
Activity Description |
---|
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. |